Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

Oral Oncology ◽  
2021 ◽  
Vol 115 ◽  
pp. 105192
Author(s):  
Douglas R. Adkins ◽  
Jin-Ching Lin ◽  
Assuntina Sacco ◽  
Jessica Ley ◽  
Peter Oppelt ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Human Papillomavirus ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Phase 2 ◽  
Double Blind ◽  
Phase 2 Trial ◽  
Randomized Phase 2

scholarly journals A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Cancer ◽  
2020 ◽  
Vol 126 (10) ◽  
pp. 2146-2152 ◽  
Author(s):  
Sara E. Kochanny ◽  
Francis P. Worden ◽  
Douglas R. Adkins ◽  
Dean W. Lim ◽  
Julie E. Bauman ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Phase 2 ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document